There was a trend towards a lower proportion of CD4+FoxP3+ regulatory T-cells in the tumor microenvironment of patients exposed to anti-PD-1 compared to control patients (p = 0.0571; Figure 5c). This evidence concerns the gene CD4 and neoplasm.